My other stock DXB raised $20m on the day they announced passing Phase 3 Efficacy Interim Analysis the SP has since doubled. The market loves fully funded companies and more so a company about to become a cash cow (BOT).
Ann: FDA Approves Sofdra, page-233
-
- There are more pages in this discussion • 322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.005(1.20%) |
Mkt cap ! $737.5M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 40.0¢ | $3.466M | 8.500M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 82195 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 301931 | 9 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |